ISDA

Entry Detail

PDB ID:

5FI2

Keywords:

Title:

Crystal structure of human GAC in complex with inhibitor UPGL_00009: 2-phenyl-~{N}-[5-[[(3~{R})-1-[5-(2-phenylethanoylamino)-1,3,4-thiadiazol- 2-yl]pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]ethanamide

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2015-12-22

Release Date:

2016-05-11

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.50 Å

R-Value Free:

0.26

R-Value Work:

0.22

R-Value Observed:

0.22

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Glutaminase kidney isoform, mitochondrial
Chain IDs:A, B, C, D
Chain Length:539
Number of Molecules:4
Biological Source:Homo sapiens

UniProt ID:O94925 Pfam ID:PF17959, PF04960 EC:3.5.1.2

Ligand Molecules

5XX

Primary Citation

Design and evaluation of novel glutaminase inhibitors.

McDermott, L.A, Iyer, P, Vernetti, L, Rimer, S, Sun, J, Boby, M, Yang, T, Fioravanti, M, O'Neill, J, Wang, L, Drakes, D, Katt, W, Huang, Q, Cerione, R.Show

Bioorg.Med.Chem. 24 1819 1839 (2016)

PMID: 26988803 DOI: 10.1016/j.bmc.2016.03.009

Abstact

A novel set of GAC (kidney glutaminase isoform C) inhibitors able to inhibit the enzymatic activity of GAC and the growth of the triple negative MDA-MB-231 breast cancer cells with low nanomolar potency is described. Compounds in this series have a reduced number of rotatable bonds, improved ClogPs, microsomal stability and ligand efficiency when compared to the leading GAC inhibitors BPTES and CB-839. Property improvements were achieved by the replacement of the flexible n-diethylthio or the n-butyl moiety present in the leading inhibitors by heteroatom substituted heterocycloalkanes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures